Literature DB >> 19059354

Measuring left ventricular function in the normal, infarcted and CORM-3-preconditioned mouse heart using complex admittance-derived pressure volume loops.

James E Clark1, Anil Kottam, Roberto Motterlini, Michael S Marber.   

Abstract

INTRODUCTION: Miniaturized conductance catheters have been successfully applied to measure left ventricular (LV) function in the mouse to assess cardiac or pharmacological interventions. Complex admittance, in contrast to existing methods using conductance catheters, produces an estimate of the parallel admittance of cardiac muscle that can be used to correct the measurement in real-time. The aim of this study was to validate the use of complex admittance to assess LV function in normal and infarcted hearts.
METHODS: Using a single conductance catheter, we directly compared measures of LV function using a specially developed admittance system (ADVantage system) and a traditional conductance-derived pressure-volume (PV) system. We subjected mice to focal myocardial ischaemia-reperfusion injury while measuring cardiac function to determine the ability of the new system to distinguish between normal, and dysfunctional LV, contractile performance.
RESULTS: LV pressure-volume loops from complex admittance is a reproducible and reliable method of determining LV function, producing data similar to that of the conductance catheter. Our data suggest that the ADVantage system records larger systolic LV cavity volumes when compared to the traditional conductance system in the same animal. In addition, we demonstrate marked LV dysfunction following coronary artery occlusion and reperfusion which is ameliorated using CORM-3, a cardioprotective agent that liberates carbon monoxide (CO).
CONCLUSION: The ADVantage system is both effective and reproducible in measuring LV function and dysfunction in the mouse, without the need for complicated interventions to calibrate the measurements. This may mark the way toward an accurate assessment of murine cardiac function.

Entities:  

Mesh:

Year:  2008        PMID: 19059354     DOI: 10.1016/j.vascn.2008.10.007

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  13 in total

Review 1.  Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation.

Authors:  Kikumi S Ozaki; Shoko Kimura; Noriko Murase
Journal:  Transplant Rev (Orlando)       Date:  2011-10-13       Impact factor: 3.943

2.  Comparative analysis of telmisartan and olmesartan on cardiac function in the transgenic (mRen2)27 rat.

Authors:  Vincent G DeMarco; Megan S Johnson; Javad Habibi; Lakshmi Pulakat; Rukhsana Gul; Melvin R Hayden; Roger D Tilmon; Kevin C Dellsperger; Nathaniel Winer; Adam T Whaley-Connell; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-05       Impact factor: 4.733

Review 3.  The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.

Authors:  Ioanna Andreadou; Efstathios K Iliodromitis; Tienush Rassaf; Rainer Schulz; Andreas Papapetropoulos; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-09-23       Impact factor: 8.739

4.  Measuring right ventricular function in the normal and hypertensive mouse hearts using admittance-derived pressure-volume loops.

Authors:  Diana M Tabima; Timothy A Hacker; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-08       Impact factor: 4.733

5.  Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis.

Authors:  Sebastien Jacquet; Xiaoke Yin; Pierre Sicard; James Clark; Gajen S Kanaganayagam; Manuel Mayr; Michael S Marber
Journal:  Mol Cell Proteomics       Date:  2009-08-31       Impact factor: 5.911

6.  Emergent role of gasotransmitters in ischemia-reperfusion injury.

Authors:  Bridgette F Moody; John W Calvert
Journal:  Med Gas Res       Date:  2011-04-27

7.  Cardiac myosin-binding protein C: a potential early biomarker of myocardial injury.

Authors:  James O Baker; Raymond Tyther; Christoph Liebetrau; James Clark; Robert Howarth; Tiffany Patterson; Helge Möllmann; Holger Nef; Pierre Sicard; Balrik Kailey; Renuka Devaraj; Simon R Redwood; Gudrun Kunst; Ekkehard Weber; Michael S Marber
Journal:  Basic Res Cardiol       Date:  2015-04-03       Impact factor: 17.165

8.  Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury.

Authors:  Wilhelm J Schwaeble; Nicholas J Lynch; James E Clark; Michael Marber; Nilesh J Samani; Youssif Mohammed Ali; Thomas Dudler; Brian Parent; Karl Lhotta; Russell Wallis; Conrad A Farrar; Steven Sacks; Haekyung Lee; Ming Zhang; Daisuke Iwaki; Minoru Takahashi; Teizo Fujita; Clark E Tedford; Cordula M Stover
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

9.  Admittance-based pressure-volume loops versus gold standard cardiac magnetic resonance imaging in a porcine model of myocardial infarction.

Authors:  Gerardus P J van Hout; Sanne J Jansen of Lorkeers; Johannes M I H Gho; Pieter A Doevendans; Wouter W van Solinge; Gerard Pasterkamp; Steven A J Chamuleau; Imo E Hoefer
Journal:  Physiol Rep       Date:  2014-04-22

10.  Cardioprotection by an anti-MASP-2 antibody in a murine model of myocardial infarction.

Authors:  James E Clark; Thomas Dudler; Michael S Marber; Wilhelm Schwaeble
Journal:  Open Heart       Date:  2018-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.